Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Progesterone R/NR3C3 Antibody (SPM566), Novus Biologicals™

Mouse Monoclonal Antibody
$243.50 - $487.50
Specifications
Antigen | Progesterone R/NR3C3 |
---|---|
Clone | SPM566 |
Dilution | Western Blot 0.5-1ug/ml, Immunohistochemistry-Paraffin 0.5-1ug/ml, Immunohistochemistry-Frozen 0.5-1.0ug/ml |
Applications | Western Blot, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen) |
Classification | Monoclonal |
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Quantity | Price | Quantity & Availability | |||||
NBP234382F
![]() |
Novus Biologicals
NBP2343820.02MG |
0.02 mg |
Each for $243.50
|
|
|||||
NBP234382A
![]() |
Novus Biologicals
NBP2343820.1MG |
0.1 mg |
Each for $487.50
|
|
|||||
NBP234382B
![]() |
Novus Biologicals
NBP2343820.2MG |
0.2 mg | N/A | N/A | N/A | ||||
Description
Progesterone R/NR3C3 Monoclonal specifically detects Progesterone R/NR3C3 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin.Specifications
Progesterone R/NR3C3 | |
Western Blot 0.5-1ug/ml, Immunohistochemistry-Paraffin 0.5-1ug/ml, Immunohistochemistry-Frozen 0.5-1.0ug/ml | |
Monoclonal | |
Purified | |
RUO | |
Human | |
P06401 | |
5241 | |
Recombinant human Progesterone Receptor protein | |
Primary | |
Store at 4C. |
SPM566 | |
Western Blot, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen) | |
Unconjugated | |
Mouse | |
Breast Cancer, Cancer | |
PBS with 0.05% BSA. with 0.05% Sodium Azide | |
NR3C3PRNuclear receptor subfamily 3 group C member 3, progesterone receptor | |
PGR | |
IgG1 κ | |
Protein A purified | |
This MAb is specific to progesterone receptor and shows minimal cross-reaction with other members of the family. Progesterone receptor is expressed as two major isoforms, PR-A (81kDa) and PR-B (116kDa). Expression of PgR has been suggested to reflect a intact estrogen regulatory machinery and therefore, predict better clinical response to endocrine therapy than ER alone. It is excellent for immunohistochemical staining of formalin/paraffin tissues. |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title